Clinical Trials in Miami

Showing 1601-1620 of 11,431 trials

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

NCT07224048

H. pylori is an infection of the stomach that can cause chronic gastritis, gastric cancer and peptic ulcer disease. The goal of this study is to screen people for this infection and offer treatment for those who test positive for the infection. By treating those who are positive for H. pylori, there is an opportunity to prevent gastritis, peptic ulcer disease, and even gastric cancer.

H. Pylori InfectionGastric CancerGastritis H Pylori

University of Miami75 participantsStarted Nov 2024

Miami, Florida, United States

COMPLETEDPhase 2< 1 mile

Single or Repeat Dose of G03-52-01 in Adult Subjects

NCT05348993

A Phase 2, randomized, double-blind, placebo-controlled single or repeat dose trial

HealthyBotulinum Toxin

U.S. Army Medical Research and Development Command622 participantsStarted Jun 2022

Mobile, Alabama, United States • Tempe, Arizona, United States • Fort Myers, Florida, United States +12 more locations

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

Single or Repeat Dose of G03-52-01 in Adult Subjects

Find Trials by Condition in Miami

Comprehensive HIV and Harm Prevention Via Telehealth

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

A Study to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents

A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Safety and Efficacy of the VERTICA® RF Device for the Treatment of ED

Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)

A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

Rice Technologies for Cervical Cancer Screening and Diagnosis

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma